FX.co ★ LeMaitre Vascular To Offer $150 Mln Of Senior Notes; Pre-Market Stock Down

LeMaitre Vascular, Inc. (LMAT), a company specializing in medical devices, announced on Monday its intention to privately offer $150 million in convertible senior notes, set to mature in 2030. The proceeds from this offering are earmarked for use as working capital and for other general corporate purposes. Additionally, LeMaitre Vascular plans to provide the initial purchasers with an option to acquire an extra $22.5 million in notes. As a result, LMAT shares experienced a 4.16% decline, trading at $96.50 in pre-market activity on the Nasdaq.